ICU Medical (NASDAQ:ICUI - Get Free Report) was downgraded by equities research analysts at StockNews.com from a "buy" rating to a "hold" rating in a research report issued to clients and investors on Thursday.
A number of other research analysts have also recently issued reports on the company. Jefferies Financial Group upgraded ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 target price on the stock in a research report on Wednesday, December 11th. Raymond James set a $97.00 price target on shares of ICU Medical in a report on Wednesday, March 12th. Two analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, ICU Medical presently has a consensus rating of "Moderate Buy" and an average target price of $168.67.
Check Out Our Latest Research Report on ICUI
ICU Medical Stock Performance
Shares of ICU Medical stock traded down $0.44 on Thursday, hitting $139.73. The stock had a trading volume of 124,992 shares, compared to its average volume of 261,541. ICU Medical has a twelve month low of $93.36 and a twelve month high of $196.26. The stock has a market cap of $3.43 billion, a price-to-earnings ratio of -30.57 and a beta of 0.73. The business's 50 day moving average is $154.42 and its two-hundred day moving average is $163.78. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75.
Insider Buying and Selling at ICU Medical
In other news, CEO Vivek Jain sold 1,373 shares of ICU Medical stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total value of $213,474.04. Following the completion of the transaction, the chief executive officer now directly owns 104,593 shares of the company's stock, valued at approximately $16,262,119.64. This trade represents a 1.30 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 6.70% of the company's stock.
Institutional Investors Weigh In On ICU Medical
Large investors have recently added to or reduced their stakes in the business. Arizona State Retirement System boosted its holdings in shares of ICU Medical by 1.0% during the 4th quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier's stock worth $1,044,000 after buying an additional 65 shares in the last quarter. Huntington National Bank lifted its position in shares of ICU Medical by 6.2% during the 4th quarter. Huntington National Bank now owns 1,402 shares of the medical instruments supplier's stock valued at $218,000 after acquiring an additional 82 shares during the period. Equitable Trust Co. boosted its stake in ICU Medical by 1.6% during the fourth quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier's stock worth $822,000 after acquiring an additional 84 shares in the last quarter. LPL Financial LLC grew its holdings in ICU Medical by 2.0% in the fourth quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier's stock worth $747,000 after purchasing an additional 93 shares during the period. Finally, Alliancebernstein L.P. increased its stake in ICU Medical by 0.5% in the fourth quarter. Alliancebernstein L.P. now owns 26,107 shares of the medical instruments supplier's stock valued at $4,051,000 after purchasing an additional 136 shares in the last quarter. Institutional investors and hedge funds own 96.10% of the company's stock.
About ICU Medical
(
Get Free Report)
ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.
Featured Articles
Before you consider ICU Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.
While ICU Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
